- $280.88m
- $82.30m
- $163.71m
- 56
- 39
- 72
- 56
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 89.1 | 157 | 204 | 191 | 164 |
Cost of Revenue | |||||
Gross Profit | 62 | 124 | 156 | 138 | 120 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 105 | 135 | 227 | 250 | 226 |
Operating Profit | -16.1 | 21.8 | -23.6 | -59.6 | -62 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -17.2 | 21.1 | -24.5 | -57.3 | -50.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17.5 | 20.8 | -24.3 | -58.2 | -51.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -17.5 | 20.8 | -24.3 | -58.2 | -51.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -32.3 | 4.05 | -24.8 | -58.2 | -51.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.727 | 0.091 | -0.57 | -1.2 | -1.05 |
Dividends per Share | |||||
Special Dividends per Share |